Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents

Shurooq Boodai, Lynne Cherry, N. Sattar, John Reilly

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Childhood and adolescent obesity is associated with insulin resistance, abnormal glucose metabolism, hypertension, dyslipidemia, inflammation, liver disease, and compromised vascular function. The purpose of this pilot study was to determine the prevalence of cardiometabolic risk factor abnormalities and metabolic syndrome (MetS) in a sample of obese Kuwaiti adolescents, as prevalence data might be helpful in improving engagement with obesity treatment in future. Eighty obese Kuwaiti adolescents (40 males) with a mean (standard deviation) age of 12.3 years (1.1 years) participated in the present study. All participants had a detailed clinical examination and anthropometry, blood pressure taken, and assessment of fasting levels of C-reactive protein, intracellular adhesion molecule, interleukin-6, fasting blood glucose, insulin, liver function tests (alanine aminotransferase, aspartate aminotransferase, gamma glutamyltransferase), lipid profile (cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides), insulin resistance by homeostasis model assessment, and adiponectin. MetS was assessed using two recognized criteria modified for use in younger individuals. The cardiometabolic risk factors with highest prevalence of abnormal values included aspartate aminotransferase (88.7% of the sample) and insulin resistance by homeostasis model assessment (67.5%), intracellular adhesion molecule (66.5%), fasting insulin (43.5%), C-reactive protein (42.5%), low-density lipoprotein cholesterol (35.0%), total cholesterol (33.5%), and systolic blood pressure (30.0%). Of all participants, 96.3% (77/80) had at least one impaired cardiometabolic risk factor as well as obesity. Prevalence of MetS was 21.3% according to the International Diabetes Federation definition and 30% using the Third Adult Treatment Panel definition. The present study suggests that obese Kuwaiti adolescents have multiple cardiometabolic risk factor abnormalities. Future studies are needed to test the benefits of intervention in this high-risk group. They also suggest that prevention of obesity in children and adults should be a major public health goal in Kuwait.
LanguageEnglish
Pages505-511
Number of pages7
JournalDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Volume7
DOIs
Publication statusPublished - 24 Oct 2014

Fingerprint

Pediatric Obesity
Insulin Resistance
Fasting
Aspartate Aminotransferases
Blood Pressure
C-Reactive Protein
LDL Cholesterol
Homeostasis
Obesity
Cholesterol
Insulin
Kuwait
Anthropometry
gamma-Glutamyltransferase
Liver Function Tests
Adiponectin
Dyslipidemias
Alanine Transaminase
HDL Cholesterol
Blood Vessels

Keywords

  • obesity
  • adolescent
  • prevalence
  • cardiometabolic risk factors
  • metabolic syndrome

Cite this

@article{2f2580681b4041aeb323e6b68e434fa5,
title = "Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents",
abstract = "Childhood and adolescent obesity is associated with insulin resistance, abnormal glucose metabolism, hypertension, dyslipidemia, inflammation, liver disease, and compromised vascular function. The purpose of this pilot study was to determine the prevalence of cardiometabolic risk factor abnormalities and metabolic syndrome (MetS) in a sample of obese Kuwaiti adolescents, as prevalence data might be helpful in improving engagement with obesity treatment in future. Eighty obese Kuwaiti adolescents (40 males) with a mean (standard deviation) age of 12.3 years (1.1 years) participated in the present study. All participants had a detailed clinical examination and anthropometry, blood pressure taken, and assessment of fasting levels of C-reactive protein, intracellular adhesion molecule, interleukin-6, fasting blood glucose, insulin, liver function tests (alanine aminotransferase, aspartate aminotransferase, gamma glutamyltransferase), lipid profile (cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides), insulin resistance by homeostasis model assessment, and adiponectin. MetS was assessed using two recognized criteria modified for use in younger individuals. The cardiometabolic risk factors with highest prevalence of abnormal values included aspartate aminotransferase (88.7{\%} of the sample) and insulin resistance by homeostasis model assessment (67.5{\%}), intracellular adhesion molecule (66.5{\%}), fasting insulin (43.5{\%}), C-reactive protein (42.5{\%}), low-density lipoprotein cholesterol (35.0{\%}), total cholesterol (33.5{\%}), and systolic blood pressure (30.0{\%}). Of all participants, 96.3{\%} (77/80) had at least one impaired cardiometabolic risk factor as well as obesity. Prevalence of MetS was 21.3{\%} according to the International Diabetes Federation definition and 30{\%} using the Third Adult Treatment Panel definition. The present study suggests that obese Kuwaiti adolescents have multiple cardiometabolic risk factor abnormalities. Future studies are needed to test the benefits of intervention in this high-risk group. They also suggest that prevention of obesity in children and adults should be a major public health goal in Kuwait.",
keywords = "obesity, adolescent, prevalence, cardiometabolic risk factors, metabolic syndrome",
author = "Shurooq Boodai and Lynne Cherry and N. Sattar and John Reilly",
year = "2014",
month = "10",
day = "24",
doi = "10.2147/DMSO.S66156",
language = "English",
volume = "7",
pages = "505--511",
journal = "Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy",
issn = "1178-7007",

}

Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents. / Boodai, Shurooq; Cherry, Lynne; Sattar, N.; Reilly, John.

In: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 7, 24.10.2014, p. 505-511.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents

AU - Boodai, Shurooq

AU - Cherry, Lynne

AU - Sattar, N.

AU - Reilly, John

PY - 2014/10/24

Y1 - 2014/10/24

N2 - Childhood and adolescent obesity is associated with insulin resistance, abnormal glucose metabolism, hypertension, dyslipidemia, inflammation, liver disease, and compromised vascular function. The purpose of this pilot study was to determine the prevalence of cardiometabolic risk factor abnormalities and metabolic syndrome (MetS) in a sample of obese Kuwaiti adolescents, as prevalence data might be helpful in improving engagement with obesity treatment in future. Eighty obese Kuwaiti adolescents (40 males) with a mean (standard deviation) age of 12.3 years (1.1 years) participated in the present study. All participants had a detailed clinical examination and anthropometry, blood pressure taken, and assessment of fasting levels of C-reactive protein, intracellular adhesion molecule, interleukin-6, fasting blood glucose, insulin, liver function tests (alanine aminotransferase, aspartate aminotransferase, gamma glutamyltransferase), lipid profile (cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides), insulin resistance by homeostasis model assessment, and adiponectin. MetS was assessed using two recognized criteria modified for use in younger individuals. The cardiometabolic risk factors with highest prevalence of abnormal values included aspartate aminotransferase (88.7% of the sample) and insulin resistance by homeostasis model assessment (67.5%), intracellular adhesion molecule (66.5%), fasting insulin (43.5%), C-reactive protein (42.5%), low-density lipoprotein cholesterol (35.0%), total cholesterol (33.5%), and systolic blood pressure (30.0%). Of all participants, 96.3% (77/80) had at least one impaired cardiometabolic risk factor as well as obesity. Prevalence of MetS was 21.3% according to the International Diabetes Federation definition and 30% using the Third Adult Treatment Panel definition. The present study suggests that obese Kuwaiti adolescents have multiple cardiometabolic risk factor abnormalities. Future studies are needed to test the benefits of intervention in this high-risk group. They also suggest that prevention of obesity in children and adults should be a major public health goal in Kuwait.

AB - Childhood and adolescent obesity is associated with insulin resistance, abnormal glucose metabolism, hypertension, dyslipidemia, inflammation, liver disease, and compromised vascular function. The purpose of this pilot study was to determine the prevalence of cardiometabolic risk factor abnormalities and metabolic syndrome (MetS) in a sample of obese Kuwaiti adolescents, as prevalence data might be helpful in improving engagement with obesity treatment in future. Eighty obese Kuwaiti adolescents (40 males) with a mean (standard deviation) age of 12.3 years (1.1 years) participated in the present study. All participants had a detailed clinical examination and anthropometry, blood pressure taken, and assessment of fasting levels of C-reactive protein, intracellular adhesion molecule, interleukin-6, fasting blood glucose, insulin, liver function tests (alanine aminotransferase, aspartate aminotransferase, gamma glutamyltransferase), lipid profile (cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides), insulin resistance by homeostasis model assessment, and adiponectin. MetS was assessed using two recognized criteria modified for use in younger individuals. The cardiometabolic risk factors with highest prevalence of abnormal values included aspartate aminotransferase (88.7% of the sample) and insulin resistance by homeostasis model assessment (67.5%), intracellular adhesion molecule (66.5%), fasting insulin (43.5%), C-reactive protein (42.5%), low-density lipoprotein cholesterol (35.0%), total cholesterol (33.5%), and systolic blood pressure (30.0%). Of all participants, 96.3% (77/80) had at least one impaired cardiometabolic risk factor as well as obesity. Prevalence of MetS was 21.3% according to the International Diabetes Federation definition and 30% using the Third Adult Treatment Panel definition. The present study suggests that obese Kuwaiti adolescents have multiple cardiometabolic risk factor abnormalities. Future studies are needed to test the benefits of intervention in this high-risk group. They also suggest that prevention of obesity in children and adults should be a major public health goal in Kuwait.

KW - obesity

KW - adolescent

KW - prevalence

KW - cardiometabolic risk factors

KW - metabolic syndrome

U2 - 10.2147/DMSO.S66156

DO - 10.2147/DMSO.S66156

M3 - Article

VL - 7

SP - 505

EP - 511

JO - Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

T2 - Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

JF - Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

SN - 1178-7007

ER -